Bern researcher viewing sample)

Research & Development

CSL Behring Research & Development

The following describes the research interests of a global organisation and includes information on products that are not yet licensed or available in the UK.

CSL Behring is a global specialty biopharmaceutical company which aims to identify, develop and commercialise important, new, biotherapeutic products that help to prevent or treat serious medical conditions. The company is committed to investing in its future product portfolio and capabilities in the areas of immunoglobulins, specialty products, haemophilia products and possible breakthrough medicines.

CSL Behring also has a strong commitment to funding research and development of protein-based medicines for unmet medical needs, which underpins its continued growth.

CSL Behring operates as one integrated global research and development organisation. We assemble co-ordinated global project teams, drawing together staff from different countries depending on their expertise. These teams rely on a project management framework that facilitates collaboration across national and cultural boundaries.

R&D Partnerships

To complement in-house expertise, we also draw on strategic partnerships with academic institutions and other organisations globally. These collaborative partnerships support a range of effective research programmes, including both basic and applied research in plasma derived and recombinant protein-based product development.

  • US $702.4 million

    was invested in R&D in 2017/18

  • US $2.9 billion

    in R&D investments in the last 5 years

  • >1,700

    research & development employees

Global R&D Network

CSL Behring is a global specialty biotech with a strong commitment to funding research and development of medicines to support its continued growth. We operate as one integrated global research and development organisation that assembles coordinated global project teams, drawing together staff from different countries depending on their expertise. Our teams rely on a project management framework that facilities collaboration across national and cultural boundaries.

CSL Parkville office
Australia

PARKVILLE, VIC
CSL Limited
Global Corporate HQ
R&D and Manufacturing

BROADMEADOWS, VIC
CSL Behring
R&D and Manufacturing

NORTH MELBOURNE, VIC
Bio21 Global Research and Translational Medicine Hub

Marburg employees
Germany

MARBURG
CSL Behring
R&D and Manufacturing

Kankakee office
United States

KING OF PRUSSIA, PA
CSL Behring
Head Office and R&D

KANKAKEE, IL
CSL Behring
R&D and Manufacturing

PASADENA, CA
Calimmune
R&D

Bern, Switzerland
Switzerland

BERN
CSL Behring
R&D and Manufacturing

Researchers taking notes
Japan

TOKYO
CSL Behring
R&D

Asian male and caucasian female in a lab
China

WUHAN
Ruide
R&D and Manufacturing

UK/CORP/18-0033c February 2019

Our Products

CSL Behring is committed to treating people with rare and serious medical conditions.

Find out more about our products
Our Patients

If you or a loved one is living with a rare or serious disease, see how our products may help.

Learn more
Focus on Rare & Serious Diseases

We are committed to improving the lives of people with rare and serious diseases worldwide.

Learn more